Asuragen announce the launch of AmplideX PCR/CE DMPK Kit for myotonic dystrophy
Abacus dx would like to update you with the latest products from Asuragen.
Asuragen have recently announced the launch of AmplideX® PCR/CE DMPK. This kit aims to simplify the analysis of repeat expansions within the DMPK gene, which is implicated in myotonic dystrophy type 1 (DM1).
As part of our release of AmplideX® PCR/CE DMPK into the ANZ market, Abacus dx would like your help and feedback on this product and use in the diagnosis of myotonic dystrophy type 1.
Benefits of AmplideX® PCR/CE DMPK Kit include:
- Sensitive detection and accurate sizing of CTG repeat expansion in the DMPK gene
- Detection of very large repeat expansions – up to 2000 repeats
- PCR-only workflow enables rapid and precise analysis of large repeats, eliminating the need for Southern Blot
- All-inclusive test kit containing all the necessary reagents to go from sample to result in a single-day workflow